MedTrace Logo

Management of Abnormally Fertilized Zygotes? InVitro Correction of 3PN

NCT02358759 · Status: COMPLETED · Phase: EARLY_PHASE1 · Type: INTERVENTIONAL · Enrollment: 22

Last updated 2016-01-12

No results posted yet for this study

Summary

In this newly developed protocol, and idea, is to manage those abnormally developed zygotes from different ART procedures.

The investigators developed the plan and requirements needed to select the target extra nucleus or pronuclei to be extruded from fertilized egg in order to maintain developing healthy normal embryo.

Conditions

Interventions

PROCEDURE

Correction of abnormally fertilized oocytes

Removing of extra developed nucleus from fertilized oocyte.

Sponsors & Collaborators

  • Ahmad Mustafa Mohamed Metwalley

    lead OTHER

Principal Investigators

  • Ahmad M Metwalley · Al Baraka Fertility Hospital

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
SINGLE_GROUP

Eligibility

Min Age
20 Years
Max Age
45 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-06-30
Primary Completion
2015-09-30
Completion
2015-09-30

Countries

  • Bahrain
  • Egypt

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02358759 on ClinicalTrials.gov